XML 51 R40.htm IDEA: XBRL DOCUMENT v3.25.1
Stock-Based Compensation and Stock Options (Details)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Mar. 28, 2024
$ / shares
shares
Mar. 08, 2023
$ / shares
shares
Jun. 01, 2022
extension
$ / shares
shares
Mar. 03, 2022
$ / shares
shares
Jan. 01, 2021
employee
$ / shares
shares
Mar. 31, 2025
USD ($)
shares
Mar. 31, 2024
USD ($)
Dec. 31, 2024
shares
Share-based Compensation Arrangement by Share-based Payment Award                
Options granted (in shares)         50,000     3,358
Number of key employees | employee         1      
Options granted, weighted average exercise price (in dollars per share) | $ / shares         $ 9.44      
Options exercised (in shares)               37,500
Options outstanding (in shares)           12,500    
March 2022 Plan                
Share-based Compensation Arrangement by Share-based Payment Award                
Options granted (in shares)       600,000        
Options granted, weighted average exercise price (in dollars per share) | $ / shares       $ 8.14        
March 2022 plan                
Share-based Compensation Arrangement by Share-based Payment Award                
Options granted (in shares)               53,753
Share-based compensation options were exercised (in shares)           400,000    
Options exercised (in shares)               200,000
June 2022 plan                
Share-based Compensation Arrangement by Share-based Payment Award                
Options granted (in shares)     100,000          
Options granted, weighted average exercise price (in dollars per share) | $ / shares     $ 6.78          
Options outstanding (in shares)           41,667    
Options vested (in shares)           25,000    
Share-based payment arrangement, nonvested award, option, cost not yet recognized, amount | $           $ 60    
March 2023                
Share-based Compensation Arrangement by Share-based Payment Award                
Options granted (in shares)   200,000           19,584
Options granted, weighted average exercise price (in dollars per share) | $ / shares   $ 4.96            
Options exercised (in shares)               75,000
Options outstanding (in shares)           125,000    
Options vested (in shares)           25,000    
March 2024                
Share-based Compensation Arrangement by Share-based Payment Award                
Options outstanding (in shares)           600,000    
Options vested (in shares)           300,000    
Number of options approved for grant by Board of Directors (in shares) 600,000              
Stock Options                
Share-based Compensation Arrangement by Share-based Payment Award                
Allocated share-based compensation expense | $           $ 0 $ 36  
Vesting percentage 25.00%              
Vesting period 6 months              
Award vesting period 2 years              
Stock Options | March 2022 Plan                
Share-based Compensation Arrangement by Share-based Payment Award                
Vesting percentage       25.00%        
Vesting period       6 months        
Award vesting period       2 years        
Stock Options | June 2022 plan                
Share-based Compensation Arrangement by Share-based Payment Award                
Allocated share-based compensation expense | $           $ 30 0  
Number of extensions | extension     3          
Expected duration for recognition of stock based compensation expense           6 months    
Stock Options | March 2023                
Share-based Compensation Arrangement by Share-based Payment Award                
Allocated share-based compensation expense | $           $ 35 35  
Vesting percentage   12.50%            
Vesting period   6 months            
Award vesting period   4 years            
Expected duration for recognition of stock based compensation expense           1 year 9 months 18 days    
Unrecognized stock-based compensation expense | $           $ 243    
Stock Options | March 2024                
Share-based Compensation Arrangement by Share-based Payment Award                
Options granted, weighted average exercise price (in dollars per share) | $ / shares $ 8.58              
Allocated share-based compensation expense | $           $ 305 $ 0  
Expected duration for recognition of stock based compensation expense           9 months 18 days    
Unrecognized stock-based compensation expense | $           $ 914